http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112578117-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70589 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70503 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2021-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112578117-B |
| titleOfInvention | Antibody composition and application thereof in screening post-transplantation lymphocyte proliferative diseases |
| abstract | The invention provides an antibody composition and application thereof in screening post-transplantation lymphoproliferative disorders (PTLD). The antibody composition comprises a first group of antibodies and a second group of antibodies, wherein the first group of antibodies comprises: anti-CD 19, anti-CD 38, anti-CD 20, anti-CD 56, and anti-CD 45 antibodies; the second group of antibodies includes: anti-cytoplasmic (c) kappa antibodies and anti-cytoplasmic lambda antibodies. The antibody composition can be used for PTLD screening of patients with fever and lymphadenectasis after transplantation, can monitor PTLD at an early stage, and has the advantages of high sensitivity, good specificity, convenient operation, simplicity, economy and high cost performance. |
| priorityDate | 2021-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.